Physics and AI Driven Precision Engineering of Novel Drugs

Pioneering expert in membrane protein structure and function to advise Verseon on its platform and pipeline development

The emergence of completely new drugs to tackle some of the world’s most prevalent diseases have been few and far between. But that could be about to change. Verseon creates drugs atom by atom, using a proprietary technology platform that goes far beyond just the application of AI

[Verseon’s] models for “de novo molecular design” can figure out which molecular structures are most likely to do which things, and they build accordingly

Verseon is changing how completely new medicines get designed, what we can treat and how well we treat them.... The company designs, atom by atom, completely novel drugs that you cannot find with any other method.... They hold the promise of completely changing the standard of care for the diseases they address because of how unique their therapeutic profiles are

"When it comes to drug discovery, AI has a data problem with which the pharmaceutical industry has not yet come to terms"

We've seen the benefits of exploring entirely novel chemical entities... We are now entering an exciting new era in drug discovery and development with immense implications for human health.

"Existing data... is a small, little tiny pittance compared to the total number of possibilities that one could explore... Asking A.I. trained on that data to suddenly change everything... is more than just asking a lot. It's not possible."

Verseon's hybrid physics- and AI-based platform reveals possibilities far outside the Pharma industry's compound libraries

Pioneering expert in membrane protein structure and function to advise Verseon on its platform and pipeline development

The emergence of completely new drugs to tackle some of the world’s most prevalent diseases have been few and far between. But that could be about to change. Verseon creates drugs atom by atom, using a proprietary technology platform that goes far beyond just the application of AI

[Verseon’s] models for “de novo molecular design” can figure out which molecular structures are most likely to do which things, and they build accordingly

Verseon is changing how completely new medicines get designed, what we can treat and how well we treat them.... The company designs, atom by atom, completely novel drugs that you cannot find with any other method.... They hold the promise of completely changing the standard of care for the diseases they address because of how unique their therapeutic profiles are

"When it comes to drug discovery, AI has a data problem with which the pharmaceutical industry has not yet come to terms"

We've seen the benefits of exploring entirely novel chemical entities... We are now entering an exciting new era in drug discovery and development with immense implications for human health.

"Existing data... is a small, little tiny pittance compared to the total number of possibilities that one could explore... Asking A.I. trained on that data to suddenly change everything... is more than just asking a lot. It's not possible."

Verseon's hybrid physics- and AI-based platform reveals possibilities far outside the Pharma industry's compound libraries